Recent evidence suggests that neuropathy is a common consequence of Nav1.7 mutations that cause pain insensitivity and it remains to be seen if targeting nociceptors with long-term silencing agents also causes neuropathy in a more general sense (McDermott et al., 2019). This evidence concerns the gene SCN9A and neuropathy.